Clearline Capital
PLXP

Clearline Capital’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Clearline Capital’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,844
Closed -$15K – 156
2022
Q3 		$15K Hold
23,844
– – ﹤0.01% 138
2022
Q2 		$58K Hold
23,844
– – 0.01% 133
2022
Q1 		$96K Buy
+23,844
New +$131K 0.01% 125

Other funds holding PLXP

Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Steel Grove Capital Advisors
Steel Grove Capital Advisors Memphis, Tennessee $1.12B AUM 20.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Clearline Capital's PLXP Position: Q4 2022 in Review

Clearline Capital sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 23,844 shares — an estimated $15K sold.

Clearline Capital first reported a position in PLXP in Q1 2022 and held it in 3 quarters. The position peaked at $96K in Q1 2022. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • Clearline Capital reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Clearline Capital sold 23,844 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $15K.
  • Clearline Capital first reported a position in PLx Pharma Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Clearline Capital's PLx Pharma Inc. Common Stock position peaked at $96K in Q1 2022.
  • 41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on Clearline Capital's 13F filing for Q4 2022, filed 14 Feb 2023.